Information about COVID-19 vaccines from the ABPI
The pharmaceutical industry is dedicated to developing effective vaccines that [...]
Risk of blood clots in cancer patients receiving immunotherapy
A recent study published in Blood has suggested that cancer [...]
Role of nephrectomy for metastatic kidney cancer in the immunotherapy era
Three phase III clinical trials (Keynote 426, Checkmate 9ER and [...]
EIKCS 2021: Future treatments for metastatic kidney cancer
Despite the advances in first-line treatments for metastatic renal cell [...]
EIKCS 2021: Biomarkers for kidney cancer
Dr Thomas Powles from St Barts Hospital, London spoke about [...]
EIKCS 2021: Second-line and later treatments for metastatic kidney cancer
The increase in the number of first-line treatments for metastatic [...]
EIKCS 2021: Combination therapies for metastatic kidney cancer: Which Approach?
The use of combination therapies for the first-line treatment of [...]
Effectiveness of second-line sunitinib after immunotherapy in metastatic kidney cancer
There is very little information on the effectiveness of sunitinib [...]
Potential role for routine brain imaging in advanced kidney cancer
A recent study published in Journal of the National Comprehensive [...]
Active surveillance of metastatic kidney cancer
Active surveillance involves closely watching a patient's condition but not [...]
